The Alliance of M&A Advisors is proud to feature this list of experts of all types:
Jeff Vlasic is trained as an Emergency Medicine physician and currently serves as Managing Partner of Vlasic & Roth LLC. He has worked in three level-I trauma centers and literally lived in the hospital during his years as a house officer. Most recently, Dr. Vlasic served as faculty at Michigan Medicine and Hurley Medical Center.
Jeff's transition from clinical medicine to entrepreneurship was in some ways inevitable. Growing up in a family with a strong tradition of business and service, he benefited from strong mentorship from his father James Vlasic, Partner at Bodman PLC, and his grandfather Robert Vlasic, founder of the Vlasic Pickle company. During his residency training, Jeff completed his second master's degree. The Health Infrastructures & Learning Systems program updated his skills to drive authentic performance improvement in complex healthcare organizations.
In 2018, Jeff transitioned to focusing exclusively on health, healthcare, and technology middle-market M&A deals. Vlasic & Roth LLC works with healthcare services and technology organizations planning for a successful exit. V&R collaborates with the executive team to manage change, withstand the scrutiny of investors, invest to multiply enterprise value, and achieve a high-reliability culture of technical and operational excellence.
Our connections to > 1 billion dollars in private capital actively seeking investment opportunities enables V&R to provide leading-edge market-based feedback to guide your organization towards exceptional results. V&R works on the buy-side for private equity investors and other clients to source and originate investment opportunities that fit their criteria. V&R has deep domain-specific expertise in the healthcare services and health technology industries. To complement comprehensive financial and legal due diligence, we evaluate how healthcare and technology organizations integrate technology with healthcare services and business strategy to increase market share, expand technical and management capabilities, reduce costs through economies of scale, achieve integration along the value chain, and multiply enterprise valuation upon exit.